Logo image of ANRG.CA

ANAERGIA INC-SUB VOTING SHR (ANRG.CA) Stock Fundamental Analysis

TSX:ANRG - Toronto Stock Exchange - CA03253E2069 - Common Stock - Currency: CAD

1.34  -0.01 (-0.74%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to ANRG. ANRG was compared to 24 industry peers in the Commercial Services & Supplies industry. ANRG has a bad profitability rating. Also its financial health evaluation is rather negative. ANRG has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year ANRG has reported negative net income.
ANRG had a negative operating cash flow in the past year.
In the past 5 years ANRG always reported negative net income.
In the past 5 years ANRG reported 4 times negative operating cash flow.
ANRG.CA Yearly Net Income VS EBIT VS OCF VS FCFANRG.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 -50M -100M -150M

1.2 Ratios

ANRG has a worse Return On Assets (-17.26%) than 75.00% of its industry peers.
Industry RankSector Rank
ROA -17.26%
ROE N/A
ROIC N/A
ROA(3y)-30.26%
ROA(5y)-19.89%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ANRG.CA Yearly ROA, ROE, ROICANRG.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 100 200 300

1.3 Margins

Looking at the Gross Margin, with a value of 22.01%, ANRG is in line with its industry, outperforming 41.67% of the companies in the same industry.
ANRG's Gross Margin has been stable in the last couple of years.
The Profit Margin and Operating Margin are not available for ANRG so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 22.01%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y7.61%
GM growth 5Y-1.13%
ANRG.CA Yearly Profit, Operating, Gross MarginsANRG.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 -50 -100

More info and screens

0

2. Health

2.1 Basic Checks

ANRG does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, ANRG has more shares outstanding
Compared to 5 years ago, ANRG has more shares outstanding
The debt/assets ratio for ANRG is higher compared to a year ago.
ANRG.CA Yearly Shares OutstandingANRG.CA Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 50M 100M 150M
ANRG.CA Yearly Total Debt VS Total AssetsANRG.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

ANRG has an Altman-Z score of -2.92. This is a bad value and indicates that ANRG is not financially healthy and even has some risk of bankruptcy.
ANRG has a Altman-Z score of -2.92. This is amonst the worse of the industry: ANRG underperforms 83.33% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -2.92
ROIC/WACCN/A
WACC7.33%
ANRG.CA Yearly LT Debt VS Equity VS FCFANRG.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M 300M

2.3 Liquidity

A Current Ratio of 0.81 indicates that ANRG may have some problems paying its short term obligations.
Looking at the Current ratio, with a value of 0.81, ANRG is doing worse than 62.50% of the companies in the same industry.
A Quick Ratio of 0.73 indicates that ANRG may have some problems paying its short term obligations.
The Quick ratio of ANRG (0.73) is worse than 66.67% of its industry peers.
Industry RankSector Rank
Current Ratio 0.81
Quick Ratio 0.73
ANRG.CA Yearly Current Assets VS Current LiabilitesANRG.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

More info and screens

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 91.01% over the past year.
The Revenue for ANRG has decreased by -17.72% in the past year. This is quite bad
The Revenue has been growing slightly by 4.47% on average over the past years.
EPS 1Y (TTM)91.01%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%79.7%
Revenue 1Y (TTM)-17.72%
Revenue growth 3Y-4.2%
Revenue growth 5Y4.47%
Sales Q2Q%-0.37%

3.2 Future

ANRG is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 318.72% yearly.
The Revenue is expected to grow by 18.38% on average over the next years. This is quite good.
EPS Next Y4.76%
EPS Next 2Y318.72%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year22.06%
Revenue Next 2Y18.38%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
ANRG.CA Yearly Revenue VS EstimatesANRG.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 50M 100M 150M
ANRG.CA Yearly EPS VS EstimatesANRG.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 0 2 -2

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ANRG. In the last year negative earnings were reported.
A Price/Forward Earnings ratio of 0.40 indicates a rather cheap valuation of ANRG.
Based on the Price/Forward Earnings ratio, ANRG is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
The average S&P500 Price/Forward Earnings ratio is at 36.28. ANRG is valued rather cheaply when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 0.4
ANRG.CA Price Earnings VS Forward Price EarningsANRG.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ANRG.CA Per share dataANRG.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3

4.3 Compensation for Growth

ANRG's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
ANRG's earnings are expected to grow with 318.72% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y318.72%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ANRG!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ANAERGIA INC-SUB VOTING SHR

TSX:ANRG (8/5/2025, 7:00:00 PM)

1.34

-0.01 (-0.74%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryCommercial Services & Supplies
Earnings (Last)05-12 2025-05-12/amc
Earnings (Next)N/A N/A
Inst Owners3.15%
Inst Owner ChangeN/A
Ins Owners24.21%
Ins Owner ChangeN/A
Market Cap227.76M
Analysts42.22
Price Target1.33 (-0.75%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)12.47%
Min EPS beat(2)-47.06%
Max EPS beat(2)71.99%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-3.39%
Min Revenue beat(2)-7.97%
Max Revenue beat(2)1.18%
Revenue beat(4)1
Avg Revenue beat(4)-22.3%
Min Revenue beat(4)-44.27%
Max Revenue beat(4)1.18%
Revenue beat(8)2
Avg Revenue beat(8)-20.38%
Revenue beat(12)2
Avg Revenue beat(12)-20.45%
Revenue beat(16)2
Avg Revenue beat(16)-21.55%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)16.67%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 0.4
P/S 2.04
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.25
EYN/A
EPS(NY)3.33
Fwd EY248.29%
FCF(TTM)-0.16
FCFYN/A
OCF(TTM)-0.1
OCFYN/A
SpS0.66
BVpS-0.36
TBVpS-0.38
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -17.26%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 22.01%
FCFM N/A
ROA(3y)-30.26%
ROA(5y)-19.89%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y7.61%
GM growth 5Y-1.13%
F-Score4
Asset Turnover0.5
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 166.44%
Cap/Sales 8.7%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.81
Quick Ratio 0.73
Altman-Z -2.92
F-Score4
WACC7.33%
ROIC/WACCN/A
Cap/Depr(3y)1470.76%
Cap/Depr(5y)2019.96%
Cap/Sales(3y)40.34%
Cap/Sales(5y)55.61%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)91.01%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%79.7%
EPS Next Y4.76%
EPS Next 2Y318.72%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-17.72%
Revenue growth 3Y-4.2%
Revenue growth 5Y4.47%
Sales Q2Q%-0.37%
Revenue Next Year22.06%
Revenue Next 2Y18.38%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y36.11%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year64.29%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y84.89%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y66.77%
OCF growth 3YN/A
OCF growth 5YN/A